{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:57:49Z","timestamp":1764251869823},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ejogrb.2024.04.040","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T16:18:57Z","timestamp":1714493937000},"page":"23-30","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intermediate-risk endometrial cancer treated with adjuvant brachytherapy using single dosimetric planning: long-term outcome and toxicity assessment"],"prefix":"10.1016","volume":"298","author":[{"given":"Abel","family":"Cordoba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houssein","family":"El Hajj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Escande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrielle","family":"Scouarnec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Narducci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Martinez Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Hudry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Pasquesoone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Mirabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric F.","family":"Lartigau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Le Tinier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2024.04.040_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0010","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/AOG.0000000000005321","article-title":"Trends in uterine cancer mortality in the United States","volume":"142","author":"Somasegar","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2017.01.003","article-title":"Prediction of lymphatic dissemination in endometrioid endometrial cancer: comparison of three risk-stratification models in a single-institution cohort","volume":"144","author":"Tuomi","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.suronc.2016.08.004","article-title":"Preoperative diagnosis of tumor grade and type in endometrial cancer by pipelle sampling and hysteroscopy: results of a French study","volume":"25","author":"Phelippeau","year":"2016","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage 1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0035","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high\u2013intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0040","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma \u2013 a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0045","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0050","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.3802\/jgo.2019.30.e53","article-title":"Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group","volume":"30","author":"Reboux","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0055","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1525-1438.2008.01198.x","article-title":"Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery","volume":"18","author":"Atahan","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.brachy.2015.02.196","article-title":"Adjuvant radiotherapy in stage II endometrial carcinoma: is brachytherapy alone sufficient for local control?","volume":"14","author":"Paydar","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.brachy.2010.10.005","article-title":"Should the organs at risk be contoured in vaginal cuff brachytherapy?","volume":"10","author":"Holloway","year":"2011","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0070","unstructured":"Hoskin P, Hellebust TP, Nout R, et al. Endometrial cancer. In: The GEC ESTRO handbook of brachytherapy. Part II: clinical practice."},{"key":"10.1016\/j.ejogrb.2024.04.040_b0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure times in the presence of competing risks","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.09.054","article-title":"Intravaginal brachytherapy alone for intermediate-risk endometrial cancer","volume":"62","author":"Alektiar","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2011.12.010","article-title":"Clinical outcomes in International Federation of Gynecology and Obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy","volume":"84","author":"Diavolitsis","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1999.5526","article-title":"Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy","volume":"75","author":"Chadha","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0095","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/gyno.1998.5155","article-title":"Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: patterns of relapse and side effects following low-dose therapy","volume":"71","author":"Weiss","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0100","first-page":"235","article-title":"Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma","volume":"99","author":"Horowitz","year":"2002","journal-title":"Obst Gynecol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0105","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","article-title":"Ten-year results of the PORTEC-2 trial for high\u2013intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy","volume":"119","author":"Wortman","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.brachy.2005.02.002","article-title":"Vaginal lymphatic channel location and its implication for intracavitary brachytherapy radiation treatment","volume":"4","author":"Choo","year":"2005","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0115","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IGC.0b013e3182643ba0","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study \u2013 quality-of-life analysis","volume":"22","author":"Sorbe","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0120","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ygyno.2005.11.004","article-title":"Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence","volume":"101","author":"Petignat","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0130","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/153303460600500509","article-title":"Comparison of 2D vs. 3D dosimetry for Rotte \u2018Y\u2019 applicator high dose rate brachytherapy for medically inoperable endometrial cancer","volume":"5","author":"Beriwal","year":"2006","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.brachy.2011.12.009","article-title":"Is there any advantage to three-dimensional planning for vaginal cuff brachytherapy?","volume":"11","author":"Kim","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.prro.2012.10.002","article-title":"Dosimetric and cost comparison of first fraction imaging versus fractional re-imaging on critical organ dose in vaginal cuff brachytherapy","volume":"3","author":"Corso","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0145","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ijrobp.2013.11.247","article-title":"Interval between hysterectomy and start of radiation treatment is predictive of recurrence in patients with endometrial carcinoma","volume":"88","author":"Cattaneo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0150","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.ejso.2017.08.004","article-title":"Prognostic value of local relapse for patients with endometrial cancer","volume":"43","author":"Dabi","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0155","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejogrb.2024.04.040_b0160","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152400215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152400215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T01:14:33Z","timestamp":1718241273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121152400215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":32,"alternative-id":["S030121152400215X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.04.040","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intermediate-risk endometrial cancer treated with adjuvant brachytherapy using single dosimetric planning: long-term outcome and toxicity assessment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.04.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}